Skip to main content
logo
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.190
+0.200 (5.01%)
At close: Nov 21, 2025, 4:00 PM EST
4.180
-0.010 (-0.24%)
After-hours: Nov 21, 2025, 7:43 PM EST

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $6.31M in the twelve months ending September 30, 2025, down -36.36% year-over-year. In the year 2024, Taysha Gene Therapies had annual revenue of $8.33M, down -46.07%.

Revenue (ttm)
$6.31M
Revenue Growth
-36.36%
P/S Ratio
197.54
Revenue / Employee
$86,438
Employees
73
Market Cap
1.15B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

TSHA News

More News